A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer
Clinical trial NCT05496192 · WITHDRAWN
Trial details
- NCT number
- NCT05496192
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2024-06-24
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.